EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Repurposing public sarcoma multi-omics for neoantigen discovery

Panagiotis Mantas, Karen A Krogfelt

Cancer Immunology, Immunotherapy · 21.04.2026 · 75 (5)

DOI: 10.1007/s00262-026-04395-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 21.04.2026. Verfasst von Panagiotis Mantas und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Technology, Technical University of Denmark, 2800, Kongens Lyngby, Denmark. panman@dtu.dk. Hauptthemen laut MEDLINE: Sarcoma, Antigens, Neoplasm, Biomarkers, Tumor. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Technical University of Denmark.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Soft tissue sarcomas, particularly complex karyotype sarcomas (CKS), are characterized as “immunologically cold” malignancies driven by structural instability rather than a high tumor mutational burden (TMB). Public “legacy” cohorts are a useful resource to uncover immunotherapy biomarkers. This study used the whole-exome sequencing (WES) and RNA-sequencing of CKS patients, to overcome technical limitations and to identify and prioritize neoantigens.

Methods

The systematic immunogenomic reanalysis was performed on a landmark cohort of CKS patients (Kim et al., 2018) with a custom bioinformatics workflow which was developed to uncover interpretable immunogenomic signals. This approach consisted of: (1) defining a quality-controlled “callable territory” and normalizing TMB metrics, respectively; (2) utilizing RNA-seq not only for expression filtering but as an orthogonal validation check for variant transcription and to distinguish functional amplifications from technical depth artifacts; and (3) applying a multi-modal epitope prediction pipeline to identify and prioritize high-affinity neoantigens derived from both somatic SNVs, indels and expressed gene fusions.

Results

The reanalysis shows that standard genome-wide metrics frequently underestimated the immunogenic potential. Normalizing the TMB refined quantitative mutation burden estimates and improved interpretation of low-coverage samples without essentially changing the overall cohort classification. Furthermore, integration of transcriptomic data facilitated the recovery of actionable targets in “low-TMB” tumors. A subset of fusion-derived peptides demonstrated predicted binding affinities competitive with SNV-derived candidates.

Conclusion

This study illustrates that technically constrained multi-omic datasets can be systematically re-analyzed to identify potential therapeutic targets. These data argue for looking beyond aggregate biomarkers; patient-specific, expressed neoepitopes may exist even in sarcomas typically described as immunologically “cold”.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcomaAntigens, NeoplasmBiomarkers, TumorHumansMultiomicsExome SequencingMutationGenomics

Stichwörter der Autor:innen

Complex karyotype sarcomasImmunogenomicsLegacy sequencingRNA-guided neoantigens

Substanzen

Antigens, NeoplasmBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Health Technology, Technical University of Denmark, 2800, Kongens Lyngby, Denmark. panman@dtu.dk.
  • Department of Science and Environment, Roskilde University, 4000, Roskilde, Denmark.

Förderung

  • Technical University of Denmark

Zitieren

APA

Mantas, P., & Krogfelt, K. A. (2026). Repurposing public sarcoma multi-omics for neoantigen discovery. Cancer Immunology, Immunotherapy, 75(5). https://doi.org/10.1007/s00262-026-04395-y

Vancouver

Mantas P, Krogfelt KA. Repurposing public sarcoma multi-omics for neoantigen discovery. Cancer Immunology, Immunotherapy. 2026;75(5). doi:10.1007/s00262-026-04395-y

BibTeX
@article{Mantas2026,
  author = {Mantas, Panagiotis and Krogfelt, Karen A},
  title = {Repurposing public sarcoma multi-omics for neoantigen discovery},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2026},
  volume = {75},
  number = {5},
  doi = {10.1007/s00262-026-04395-y}
}
Kostenlos starten →